Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

被引：1
|
作者：
Milligan, DW [1 ]
Wheatley, K
Burnett, AK
机构：
[1] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5ST, W Midlands, England
[2] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England
[3] Univ Wales Coll Med, Dept Haematol, Cardiff CF4 4XN, S Glam, Wales
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 127卷 / 02期
关键词：
acute myeloid leukaemia; fludarabine;
D O I：
10.1111/j.1365-2141.2004.05185.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：238 / 239
页数：3
相关论文
共 50 条
  • [1] Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes
    Virchis, A
    Koh, M
    Rankin, P
    Mehta, A
    Potter, M
    Hoffbrand, AV
    Prentice, HG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (01) : 26 - 32
  • [2] Fludarabine, cytarabine, and granulocyte-colony stimulating factor for the treatment of high risk myelodysplastic syndromes
    Ferrara, F
    Leoni, F
    Pinto, A
    Mirto, S
    Morra, E
    Zagonel, V
    Mele, G
    Ciolli, S
    Magrin, S
    Montillo, M
    [J]. CANCER, 1999, 86 (10) : 2006 - 2013
  • [3] Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
    Economopoulos, T
    Papageorgiou, E
    Stathakis, N
    Constantinidou, M
    Parharidou, A
    Kostourou, A
    Dervenoulas, J
    Raptis, S
    [J]. LEUKEMIA RESEARCH, 1996, 20 (05) : 385 - 390
  • [4] GRANULOCYTE-MONOCYTE AND GRANULOCYTE-COLONY STIMULATING FACTORS IN MYELODYSPLASTIC SYNDROMES
    NAGLER, A
    GREENBERG, PL
    [J]. LEUKEMIA & LYMPHOMA, 1991, 5 (04) : 219 - 230
  • [5] A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes
    Invernizzi, R
    Pecci, A
    Iannone, AM
    DAlessio, A
    Giusto, M
    Rossi, G
    Dezza, L
    Ascari, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 864 - 864
  • [6] Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes
    Invernizzi, R
    Pecci, A
    Rossi, G
    Pelizzari, AM
    Giusto, M
    Tinelli, C
    Ascari, E
    [J]. HAEMATOLOGICA, 1997, 82 (06) : 660 - 663
  • [7] Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF)
    Montillo, M
    Tedeschi, A
    Centurioni, R
    Leoni, P
    [J]. LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 579 - 583
  • [8] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR
    NEGRIN, RS
    HAEUBER, DH
    NAGLER, A
    SOUZA, LM
    GREENBERG, PL
    [J]. EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 519 - 519
  • [9] TREATMENT WITH CYTOSINE-ARABINOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ITS LEUKEMIC PHASE
    IM, T
    YAMANE, T
    MUGITANI, A
    HIYOSHI, M
    PARK, K
    TATSUMI, N
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 1994, 60 (03) : 215 - 223
  • [10] The role of fludarabine, cytarabine, idarubicin and granulocyte-colony stimulating factor as salvage treatment before or after haernatopoietic stem cell transplant
    Ong, TC
    Chew, TK
    Tan, SM
    Sathar, J
    Chang, KM
    Purushothaman, V
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S377 - S378
12345